Fords, NJ, United States of America

Hiren V Patel



Average Co-Inventor Count = 3.8

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Edison, NJ (US) (2001 - 2005)
  • Fords, NJ (US) (2007 - 2013)

Company Filing History:


Years Active: 2001-2013

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Hiren V Patel: Innovator in Pharmaceutical Processes

Introduction

Hiren V Patel is a notable inventor based in Fords, NJ (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 6 patents. His work primarily focuses on innovative processes for preparing polypeptides and other pharmaceutical compounds.

Latest Patents

One of his latest patents is titled "Processes for preparing a polypeptide." This invention relates to an improved method for preparing a polypeptide or pharmaceutically acceptable salt thereof, which includes L-tyrosine, L-alanine, L-glutamate, and L-lysine. The preferred product of this process is glatiramer acetate. The method involves polymerizing a mixture of N-carboxyanhydrides in a polar aprotic solvent, followed by a series of steps to form a deprotected polypeptide or its salt. Another significant patent is the "Process of preparation of olanzapine form I," which details a method for preparing polymorph Form I of olanzapine, a compound used in the treatment of schizophrenia.

Career Highlights

Hiren V Patel has worked with prominent companies in the pharmaceutical industry, including Geneva Pharmaceuticals, Inc. and Sandoz AG. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical processes.

Collaborations

Throughout his career, Hiren has collaborated with notable professionals in the field, including Anup Kumar Ray and Mahendra R Patel. These collaborations have further enhanced his contributions to pharmaceutical innovations.

Conclusion

Hiren V Patel's work in the pharmaceutical industry exemplifies the impact of innovation on healthcare. His patents reflect a commitment to advancing drug development processes, ultimately benefiting patients and the medical community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…